Tag: Lobe Sciences - Psilocybin Alpha

New Resource: Psychedelics Drug Development Tracker

Lobe Sciences Acquires Vitamind Line of Wellness Products

Lobe Sciences Acquires Vitamind Line of Wellness Products

Post published:May 4, 2021
Post category:Press Release

Lobe Sciences Announces Filing of PCT Application

Lobe Sciences Announces Filing of PCT Application

Post published:April 29, 2021
Post category:Press Release

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

Post published:April 27, 2021
Post category:Press Release

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board

Post published:April 20, 2021
Post category:Press Release

Lobe Sciences Appoints Ilan Hayman to Advisory Board

Lobe Sciences Appoints Ilan Hayman to Advisory Board

Post published:April 6, 2021
Post category:Press Release

Lobe Sciences Becomes Enterprise Member of NFL Alumni Association

Lobe Sciences Becomes Enterprise Member of NFL Alumni Association

Post published:March 31, 2021
Post category:Press Release

Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands

Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands

Post published:March 8, 2021
Post category:Press Release

Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board

Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board

Post published:March 3, 2021
Post category:Press Release

Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

Post published:February 23, 2021
Post category:Press Release

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Post published:February 18, 2021
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.